Corey Dade leads Buoyant Health, advising life sciences companies, health organizations, and foundations on engagement strategies that strengthen trust, increase participation, and drive measurable market performance.
He works at the intersection of commercial strategy, public policy, and community trust — helping organizations move from awareness to sustained action in markets where engagement has historically been uneven.
His healthcare work includes:
Engagement strategy for BridgeBio Pharma in support of Attruby (acoramidis), integrating community engagement, narrative strategy, and in-market activation.
Health equity brand strategy for Gilead Sciences, including media strategy for breakthrough clinical trial results for the HIV prevention injection Sunlenca (lenacapavir).
Stakeholder engagement and policy advocacy for the American Kidney Fund and the American Physiological Society.
Media strategy for Together for Supportive Cancer Care, a national coalition advancing equitable access to cancer care.
Reputation and engagement strategy for Pfizer, Novartis, and Johnson & Johnson.
A former journalist at The Wall Street Journal, The Boston Globe, and NPR, Corey applies more than 20 years of storytelling, coalition-building, and policy communications to the design of engagement strategies that resonate in communities, while advancing business and public health outcomes.Valarie brings a deep national network across provider associations, patient advocacy organizations, and community institutions to her work translating relationship capital into sustained participation and measurable impact.